查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679363

北美和歐洲靜脈輸液幫浦市場規模、佔有率、趨勢分析報告：按產品、適應症、最終用途、地區和細分市場預測，2025 年至 2030 年

North America And Europe Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Disease Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

市場規模和趨勢

預計北美和歐洲靜脈輸液幫浦市場規模到 2024 年將達到 44.5 億美元，2025 年至 2030 年的複合年成長率為 8.10%。

這種成長是由於呼吸系統疾病、中風、糖尿病、癌症和心血管疾病等慢性疾病的盛行率不斷上升所致，心血管疾病是歐洲和北美的主要死亡原因。例如，根據美國衛生與公眾服務部的數據，估計美國有 1.29 億人患有至少一種主要慢性病。靜脈輸液幫浦在患者接受放射線治療或化療期間提供受管制、協調且無錯誤的營養物質和藥物傳遞。使用這些泵浦可以減少管理過程中的錯誤。用藥錯誤是最常見的錯誤類型，在治療慢性病患者時不能掉以輕心。

我們需要更安全、更有效率、更標準化的先進輸送系統。智慧型輸液幫浦和下一代靜脈幫浦的推出為整個幫浦市場創造了巨大的成長機會。智慧型幫浦是一種採用電腦軟體系統的輸液設備，旨在透過藥物庫來減少藥物管理錯誤並確保安全用藥。例如，2024 年 4 月，加拿大的 Mackenzie Health 成為第一個部署 BD Alaris EMR互通性的醫療系統，實現了輸液幫浦和電子健康記錄(EMR) 之間的雙向通訊。這項進步消除了手動編程的需要，顯著減少了用藥錯誤，同時提高了工作流程效率。研究表明，輸液編程所需的擊鍵次數減少了 86%。這種智慧輸液技術正在推動醫院對可互通和自動輸液幫浦的需求，從而推動市場成長。

先進輸液幫浦技術的監管核准是靜脈輸液幫浦市場的關鍵市場驅動力，可提高醫療保健環境中的病患安全性、效率和連結性。例如，2024 年 4 月，百特國際公司 (Baxter International Inc.) 的配備 Dose IQ 安全軟體的 Novum IQ 大容量輸液幫浦最近獲得了 FDA 510(k) 許可，從而擴展了其 Novum IQ 輸液平台。此整合系統包括大容量泵和注射式幫浦，使臨床醫生能夠在多個護理站點使用單一連接平台，提高工作流程效率並減少用藥錯誤。隨著醫院擴大採用智慧、可互通的輸液技術，對下一代輸液幫浦的需求預計將大幅成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 北美和歐洲靜脈輸液幫浦市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 北美和歐洲靜脈輸液幫浦市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章北美和歐洲靜脈輸液幫浦市場-產品、估計和趨勢分析

  • 北美和歐洲靜脈輸液幫浦市場：產品儀表板
  • 北美和歐洲靜脈輸液幫浦市場：產品差異分析
  • 2018-2030年北美及歐洲靜脈輸液幫浦市場規模、預測及趨勢分析（依產品）
  • 容積式輸液泵
  • 注射輸液幫浦
  • 攜帶式輸液泵
  • 患者自控鎮痛輸液泵
  • 植入式輸液泵
  • 其他

5. 北美和歐洲靜脈輸液幫浦市場（按疾病適應症、估計和趨勢分析）

  • 北美和歐洲靜脈輸液幫浦市場：疾病指徵儀表板
  • 北美及歐洲靜脈輸液幫浦市場：疾病適應症變異分析
  • 2018 年至 2030 年北美及歐洲靜脈輸液幫浦市場規模、預測及疾病適應症趨勢分析
  • 化療
  • 糖尿病
  • 胃腸病學
  • 鎮痛/疼痛管理
  • 小兒科/新生兒科
  • 血液學
  • 其他

6. 北美和歐洲靜脈輸液幫浦市場最終用途、預測和趨勢分析

  • 北美和歐洲靜脈輸液幫浦市場：最終用途儀表板
  • 北美和歐洲靜脈輸液幫浦市場：最終用途差異分析
  • 2018-2030年北美及歐洲靜脈輸液幫浦市場規模、預測及趨勢分析（依最終用途）
  • 醫院
  • 居家醫療
  • 其他

7. 北美和歐洲靜脈輸液幫浦市場-按國家、產品、疾病適應症、最終用途區域進行的估計和趨勢分析

  • 北美和歐洲靜脈輸液幫浦市場：區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥

第8章競爭格局

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024 年主要企業的市場佔有率分析
    • Baxter
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • ICU Medical, Inc.（Smiths Medical）
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • BD
    • Terumo Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Moog Inc.
    • IRadimed Corporation
    • CODAN Companies
    • Arcomed
Product Code: GVR-4-68040-528-7

Market Size & Trends:

The North America and Europe intravenous infusion pumps market size was valued at USD 4.45 billion in 2024 and is projected to grow at a CAGR of 8.10% from 2025 to 2030. This growth is attributed to the increase in the prevalence of chronic diseases such as respiratory diseases, stroke, diabetes, cancer, and cardiovascular diseases, wherein cardiovascular disease is the major cause of death in Europe and North America. For instance, according to the U.S. Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. Intravenous infusion pumps ensure controlled, regulated, & error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex processes and require precise dosages of medication. The use of these pumps helps in reducing errors during administration, as medication errors are the most common types of errors and cannot be taken carelessly while handling patients with chronic diseases.

There is a need for advanced delivery systems that are safer, more efficient, and standardized. The introduction of smart infusion pumps or next-generation intravenous pumps is imparting greater growth opportunities for the overall pump market. Smart pumps are infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries, ensuring safe medication administration. For instance, in April 2024, Mackenzie Health in Canada became the first healthcare system to implement BD Alaris EMR Interoperability, enabling two-way communication between IV infusion pumps and electronic medical records (EMRs). This advancement eliminates the need for manual programming, significantly reducing medication administration errors while improving workflow efficiency. Studies show an 86% reduction in keystrokes needed for infusion programming. Such smart infusion technologies are driving market growth by increasing hospital demand for interoperable and automated IV pumps.

Regulatory approvals of advanced infusion pump technologies are a key market driver for the intravenous infusion pump market, improving patient safety, efficiency, and connectivity in healthcare settings. For instance, in April 2024, Baxter International Inc. recently received FDA 510(k) clearance for its Novum IQ large volume infusion pump with Dose IQ Safety Software, expanding its Novum IQ Infusion Platform. This integrated system, which includes both large volume and syringe pumps, allows clinicians to use a single, connected platform across multiple care settings, enhancing workflow efficiency and reducing medication errors. As hospitals increasingly adopt smart, interoperable infusion technologies, demand for next-generation IV pumps is expected to grow significantly.

North America And Europe Intravenous Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America and Europe intravenous infusion pumps market report on the basis of product, disease indication, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others
  • Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Homecare
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Indication
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. Disease Indication Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of chronic diseases
      • 3.2.1.2. Technological advancements in infusion pumps
      • 3.2.1.3. Rising demand for ambulatory infusion pumps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement
      • 3.2.2.2. Increasing product recalls
  • 3.3. North America and Europe Intravenous Infusion Pumps Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. North America and Europe Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis

  • 4.1. North America and Europe Intravenous Infusion Pumps Market: Product Dashboard
  • 4.2. North America and Europe Intravenous Infusion Pumps Market: Product Movement Analysis
  • 4.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Volumetric Infusion Pumps
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Syringe Infusion Pumps
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Ambulatory Infusion Pumps
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Patient-Controlled Analgesia Infusion Pumps
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.8. Implantable Infusion Pumps
    • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

  • 5.1. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Dashboard
  • 5.2. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • 5.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Diabetes
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Gastroenterology
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Analgesia/Pain Management
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.8. Pediatrics/Neonatology
    • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.9. Hematology
    • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. North America and Europe Intravenous Infusion Pumps Market: End-use Estimates & Trend Analysis

  • 6.1. North America and Europe Intravenous Infusion Pumps Market: End-use Dashboard
  • 6.2. North America and Europe Intravenous Infusion Pumps Market: End-use Movement Analysis
  • 6.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. North America and Europe Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Disease Indication, and End-use

  • 7.1. North America and Europe Intravenous Infusion Pumps Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Baxter
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. End-use benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun Melsungen AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. End-use benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Fresenius Kabi AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. End-use benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. ICU Medical, Inc. (Smiths Medical)
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. End-use benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Micrel Medical Devices SA
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. End-use benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Boston Scientific Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. End-use benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. BD
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. End-use benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Terumo Corporation
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. End-use benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. End-use benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Moog Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. End-use benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. IRadimed Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. End-use benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. CODAN Companies
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. End-use benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Arcomed
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. End-use benchmarking
      • 8.3.16.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America & Europe Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 4. North America & Europe Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million) (Volume Unit)
  • Table 5. North America & Europe Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 6. North America & Europe Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7. North America Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 8. North America Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 9. North America Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 10. North America Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 11. U.S. Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 12. U.S. Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14. Canada Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 15. Canada Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 16. Canada Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Mexico Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. Mexico Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 19. Mexico Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20. Europe Intravenous Infusion Pumps Market, by Country, 2018 - 2030 (USD Million)
  • Table 21. Europe Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. Europe. Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 23. Europe Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 24. Germany Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 25. Germany Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 26. Germany Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27. UK Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 28. UK Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 29. UK Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. France Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 31. France Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 32. France Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. Italy Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 34. Italy Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 35. Italy Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36. Spain Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 37. Spain Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 38. Spain Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 39. Denmark Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 40. Denmark Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 41. Denmark Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Sweden Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Sweden Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 44. Sweden Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45. Norway Intravenous Infusion Pumps Market, by Product, 2018 - 2030 (USD Million)
  • Table 46. Norway Intravenous Infusion Pumps Market, by Disease Indication, 2018 - 2030 (USD Million)
  • Table 47. Norway Intravenous Infusion Pumps Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Participant's Overview
  • Table 49. Financial Performance
  • Table 50. Product Benchmarking
  • Table 51. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Market Formulation & Validation
  • Fig. 5 Intravenous Infusion Pumps Market, Market Segmentation
  • Fig. 6 Market Driver Analysis (Current & Future Impact)
  • Fig. 7 Market Restraint Analysis (Current & Future Impact)
  • Fig. 8 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 North America & Europe Intravenous Infusion Pumps Market, for Ultrasound, 2018 - 2030 (USD Million)
  • Fig. 14 North America & Europe Intravenous Infusion Pumps Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 North America & Europe Intravenous Infusion Pumps Market, for Volumetric Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 16 North America & Europe Intravenous Infusion Pumps Market, for Syringe Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 17 North America & Europe Intravenous Infusion Pumps Market, for Ambulatory Infusion Pumps, 2018 - 2030 (USD Million) (Procedure Volume)
  • Fig. 18 North America & Europe Intravenous Infusion Pumps Market, for Patient-Controlled Analgesia Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 19 North America & Europe Intravenous Infusion Pumps Market, for Implantable Infusion Pumps, 2018 - 2030 (USD Million)
  • Fig. 20 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 21 North America & Europe Intravenous Infusion Pumps Market, for Disease Indication, 2018 - 2030 (USD Million)
  • Fig. 22 North America & Europe Intravenous Infusion Pumps Market, for Chemotherapy, 2018 - 2030 (USD Million)
  • Fig. 23 North America & Europe Intravenous Infusion Pumps Market, for Diabetes, 2018 - 2030 (USD Million)
  • Fig. 24 North America & Europe Intravenous Infusion Pumps Market, for Gastroenterology, 2018 - 2030 (USD Million)
  • Fig. 25 North America & Europe Intravenous Infusion Pumps Market, for Analgesia/Pain Management, 2018 - 2030 (USD Million)
  • Fig. 26 North America & Europe Intravenous Infusion Pumps Market, for Pediatrics/Neonatology, 2018 - 2030 (USD Million)
  • Fig. 27 North America & Europe Intravenous Infusion Pumps Market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 28 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 North America & Europe Intravenous Infusion Pumps Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 30 North America & Europe Intravenous Infusion Pumps Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 31 North America & Europe Intravenous Infusion Pumps Market, for Homecare, 2018 - 2030 (USD Million)
  • Fig. 32 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Outlook, 2024 & 2030
  • Fig. 34 North America Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Intravenous Infusion Pumps Market, 2018 - 2030 (USD Million)